title: What is the optimal pharmacological management of retained placenta?
authors: Department of Primary Care Health Sciences, University of Oxford, Oxford, UK james.duffy@balliol.ox.ac.uk.
authors: James M N
authors: JM
authors: Duffy
authors: School of Health and Related Research, University of Sheffield, Sheffield, UK.
authors: Matthew J A
authors: MJ
authors: Wilson
authors: Women's Health Research Unit, Blizard Institute, Barts and the London School of Medicine and Dentistry, London, UK.
authors: Khalid S
authors: KS
authors: Khan
mesh_terms: D004333:Drug Administration Routes; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D005996:Nitroglycerin / Q000008:administration & dosage; D010120:Oxytocics / Q000008:administration & dosage; D010121:Oxytocin / Q000008:administration & dosage; D018743:Perinatal Care / Q000379:methods; D018457:Placenta, Retained / Q000188:drug therapy*; D011247:Pregnancy; D011453:Prostaglandins / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic
chemical_list: D010120:Oxytocics; D011453:Prostaglandins; D010121:Oxytocin; D005996:Nitroglycerin